drugset / Trial / NCT00932321

Study of Safety and Efficacy of an Oral Contraceptive

NCT00932321

Phase 3 Completed 938 enrolled Warner Chilcott
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding of norethindrone acetate/ethinyl estradiol (NETA/EE) administered for 24 days and NETA/EE administered for 21 days; and to assess the safety and tolerability of the product.

Timeline

Start
2004-01
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 1 mg Oral
Subject ethinyl estradiol Small molecule 20 ug Oral

Indications

No indication recorded.